ArticleInnovations in pharmacy2020

More Unnecessary Imaginary Worlds - Part 2: The ICER Evidence Report on Modeling Oral Semaglutide for Type 2 Diabetes.

Paul C LangleyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.